Analysis clarifies graft-versus-host disease risk in Hodgkin lymphoma survivors, suggesting implications for transfusion practices.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
DeStefano et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: